Question 1

How will the $50k raised, be used?

Accepted Answer

Hi Sam. In the present plan (which might change): $50k, the smallest permissible raise amount on Wefunder, to test whether the (patented) drug can slow human tissue aging.

Question 2

From LinkedIn page, there's only one team member. Which is Dr. Michael Forrest? are you a solopreneur? Why there's only you? Also, why there's no official website for this business?

Accepted Answer

Single founder: Dr. Michael Forrest. Company now edging out of "stealth mode" (commonly employed by biopharma companies early on): website to come (will be at https://biophysicaltherapeutics.com).

Question 3

I've invested in a couple startups affiliated with George Church. Some go straight for human trials, others have taken the easier veterinarian route. Different paths (regulatory, time frame, risks), etc. You're going the low-regulatory route with cosmetics. I understand the be...

Accepted Answer

PROJECTION: This relatively small target raise is primarily to manufacture the first skincare units (product on the market milestone hit), generating first revenue (first revenue milestone hit), and hopefully bringing the company into profit (profitability milestone hit), profit that can be reinvested to generate greater profit conferring "default-alive" status (not dependent on investors to survive milestone hit), which are each and all milestones that most biotech companies fail to reach - ...

Question 4

Hi Dr. Forrest, What is the single most important milestone you expect to achieve in the next 12–18 months that would materially increase the company’s valuation or attract a partnership with a major pharmaceutical company? What evidence will you have at that point, and what w...

Accepted Answer

PROJECTION: This relatively small target raise is primarily to manufacture the first skincare units (product on the market milestone hit), generating first revenue (first revenue milestone hit), and hopefully bringing the company into profit (profitability milestone hit), profit that can be reinvested to generate greater profit conferring "default-alive" status (not dependent on investors to survive milestone hit), which are each and all milestones that most biotech companies fail to reach - ...

Question 5

Hi Dr. Forrest, I just invested and, reading through the comments, I see several smart and important questions have already been raised by other investors. Many of them are questions I have too. Rather than repeat them, could you share an update on where the company stands tod...

Accepted Answer

Hi Claudia. Thank you. Please see my response to Glenn above. Belated for which I apologize to him and all. Thank you again Claudia for your support.

Invest in Biophysical Therapeutics

Anti-Aging Breakthrough from PhDs

$71,320

What Investors Say

Biophysical Therapeutics

Quick facts

Team profiles

Featured investor profiles

$71,320

What Investors Say